RB
Regen Bio
Regen Bio focuses on developing novel small molecule therapeutics targeting inflammatory and autoimmune diseases. The company utilizes proprietary screening platforms to identify and optimize compounds with high specificity and favorable pharmacokinetic profiles. Their pipeline aims to address significant unmet medical needs in chronic inflammatory conditions through targeted intervention.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Regen Bio focuses on developing novel small molecule therapeutics targeting inflammatory and autoimmune diseases. The company utilizes proprietary screening platforms to identify and optimize compounds with high specificity and favorable pharmacokinetic profiles. Their pipeline aims to address significant unmet medical needs in chronic inflammatory conditions through targeted intervention.